Navigation Links
Ventaira Pharmaceuticals Announces Acquisition of Assets by Battelle
Date:10/29/2007

COLUMBUS, Ohio, Oct. 29 /PRNewswire/ -- Ventaira Pharmaceuticals announced today that Battelle, a science and technology development leader, will acquire Ventaira's assets and assist Ventaira in closing its operations. Financial terms of the acquisition were not disclosed.

"We will be working with Battelle to transition our assets. In addition, we will work closely with Battelle to explore employment opportunities for our employees," said Leslie Williams, President and CEO of Ventaira Pharmaceuticals. "I would like to thank all of our investors and employees for their dedication to Ventaira and our technology."

Ventaira's clinical development program and device development work are discontinued effective today, Oct. 29, 2007. Operations at Ventaira are expected to close by Dec. 31, 2007.

About Ventaira

Ventaira is a specialty pharmaceutical company based in Columbus, Ohio that develops a proprietary pulmonary drug delivery technology, Mystic(TM) (Electrohydrodynamic-EHD), and formulation capabilities to deliver drugs more efficiently to and through the lung. EHD is an electronic nebulization process in which an electrical field is applied to a conductive liquid leading to the formation of a soft mist droplet aerosol. Ventaira was spun out from Battelle in 2000.

About Battelle

Battelle provides solutions to some of the world's most important challenges through its three global businesses: National Security, Energy Technology, and Health and Life Sciences. Battelle is the world's largest independent research and development organization with technology contributions that find their way into hundreds of commercial products each year. Conducting $3.8 billion in global R&D annually, Battelle oversees 20,000 employees in more than 120 locations worldwide, including five national laboratories Battelle manages or co-manages for the U.S. Department of Energy.

Headquartered in Columbus, Ohio, and established in 1929 as a non-pr
'/>"/>

SOURCE Ventaira Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Merge announces sofware updates, upcoming acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013  On May ... FCN ), the global business advisory firm dedicated ... value (the "Company"), announced that it has combined ... were formerly included within the Corporate Finance/Restructuring segment ... segment to form a single integrated practice whose ...
(Date:5/21/2013)... 2013 Alpha Source, Inc., a ... be exhibiting for the 13th consecutive year at ... (AAMI) 2013 Conference and Expo. The conference brings ... manufacture healthcare technologies. This year’s event will be ... , The three-day event draws over 1,500 ...
(Date:5/21/2013)... ALBANY, New York , May 21, 2013 /PRNewswire/ ... published by Transparency Market Research ( http://www.transparencymarketresearch.com ) "Biochip ... Science Research, IVD Tests) - U.S. Industry Analysis, Size, Share, ... USD 2.4 billion in 2011 and is expected to ... 2018, to reach an estimated value of USD 4.7 ...
(Date:5/21/2013)... 21, 2013  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... serious infectious diseases, announced today that Jeffrey Riley ... Annual Marcum LLP MicroCap Conference on Thursday, May 30, 2013 ... Grand Hyatt Hotel. Mr. Riley is scheduled to present at ... Synthetic Biologics, presentation can be accessed by logging onto the ...
Breaking Biology Technology:FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice 2Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2
... the more difficult challenges in business is turning around a ... and the company is forced into bankruptcy. Realizing the painful ... or impossible for owners and senior executives to deal with ... save them, and they will close that big outstanding proposal, ...
... escalate at a double-digit pace in 2003, but there are ... next year, according to global HR outsourcing and consulting firm ... 12.6 percent average increase for employers, which is lower than ... to absorb the majority of next year's increase, but many ...
... business conditions provide a golden opportunity to tune your ... appear to have calmed, the long-term winners will be ... winning strategies. Real competitive advantage comes from making ... fundamentally aligning your talent management practice to that choice, ...
Cached Biology Technology:Turning Around a Sick Company 2Health Care Costs Continue Double-Digit Pace, But May Start Moderating in 2004 2Health Care Costs Continue Double-Digit Pace, But May Start Moderating in 2004 3Talent Constellations or Talent Communities Choosing the Right Talent 2Talent Constellations or Talent Communities Choosing the Right Talent 3
(Date:5/22/2013)... Lung Screening Trial (NLST) investigators also conclude that ... with low-dose computed tomography (LDCT) versus chest X-ray ... paper is achievable at experienced screening centers in ... information to share with their patients about the ... following today,s publication in the New England ...
(Date:5/22/2013)... can detect molecular variants in chemical mixtures greatly ... important, though time-consuming, processes in analytical chemistry. , ... post-doctoral researcher David Patterson, Professor of Physics John Doyle ... Laser Science (CFEL) in Hamburg, Germany developed a system ... variants apart, and to determine how much variant is ...
(Date:5/22/2013)... fatty acids in fish oil have long been thought ... American Heart Association currently recommends eating at least two ... in omega 3s. However, the mechanism behind this protective ... scientists led by Jason R. Carter of Michigan Technological ... that fish oil might specifically counteract the detrimental effects ...
Breaking Biology News(10 mins):NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3Detecting mirror molecules 2Detecting mirror molecules 3Fish oil may help the heart beat mental stress 2
... living in the deep sea, it seems that there is ... it,s generally best to be transparent. But in the deeper ... as searchlights, it,s much better to go in darker colors. ... 10 in Current Biology , a Cell Press publication. ...
... 10, 2011 ─ (BRONX, NY) ─ Researchers at then ... Yeshiva University have uncovered a mechanism that governs how ... implications for human health and disease and appear in ... Cell . A fundamental question in biology ...
... weed that clogs waterways around the world has at least ... for boats and submarines. The Brazilian fern Salvinia ... part because its surface is dotted with oddly shaped hairs ... afloat. In the November 1 issue of the ...
Cached Biology News:For deep-sea cephalopods, 'switchable' camouflage saves the day 2Einstein researchers discover key to cell specialization 2Plant with 'eggbeater' testure inspires waterproof coating 2Plant with 'eggbeater' testure inspires waterproof coating 3
... Red, 20X Immunogen ... 20X concentration for use in KinEASE™ ... Quality Assurance Routinely ... polarization assays. Stability ...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Rabbit anti-NFkB p105/p50 (Ser337) Class: Antibody Product Group: Signalling molecules and phospho-specific Antibody...
Biology Products: